To understand the biological significance of SCAP in the development and progression of lung cancer, especially in patients with NSCLC, we evaluated the levels of SCAP and its ligand SREBP-1 in lung cancer specimens (n = 98) through IHC staining (Figure 1A,B). Here, SREBF1 is linked to lung carcinoma.